Citizens Maintains Market Outperform on AMERISAFE, Lowers Price Target to $45

Benzinga Newsdesk www.benzinga.com Negative 95.3%

Neg 95.3% Neu 0% Pos 0%

Citizens analyst Matthew Carletti maintains AMERISAFE (NASDAQ:AMSF) with a Market Outperform and lowers the price target from $50 to $45.